查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
醫學圖像分析軟體市場：2019-2029 年全球市場規模、佔有率、趨勢分析、機遇和預測報告
市場調查報告書
商品編碼
1301831

醫學圖像分析軟體市場：2019-2029 年全球市場規模、佔有率、趨勢分析、機遇和預測報告

Medical Image Analysis Software Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Software ; By Modality ; By Imaging ; By Application ; By End User ; By Region
出版日期: | 出版商: Blueweave Consulting | 英文 400 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

到 2029 年，全球醫學圖像分析軟體市場將超過 56.2 億美元

全球醫學圖像分析軟體市場受到超聲成像設備（尤其是用於快速診斷疑難雜症）以及技術先進的醫學成像設備（如多模態成像平台和3D成像）的日益使用的推動，並由於招聘的增加而蓬勃發展。

領先的戰略諮詢和市場研究公司 BlueWeave Consulting 最近估計，2022 年全球醫學圖像分析軟體市場價值將達到 33 億美元。 BlueWeave預測，在2023-2029年預測期內，全球醫學圖像分析軟體市場規模將以7.80%的年複合成長率成長，到2029年將達到56.2億美元。特別是，擴大使用超聲成像設備來快速診斷疑難雜症，這被認為推動了對醫學圖像分析軟體的需求。除了擴大採用多模態成像平台和 3D 成像等技術先進的產品外，使用這些系統的高解析度成像、易用性和靈活性等優勢也正在幫助增加對老年人口的增加導致慢性病的數量增加。此類疾病的日益流行可能會增加診斷成像技術的使用並加強醫學圖像分析軟體的市場。

該報告的詳細分析提供了有關全球醫學圖像分析軟體市場的成長潛力、未來趨勢和統計數據的資訊。它還涵蓋了推動市場總規模預測的因素。該報告提供了全球醫學圖像分析軟體市場的最新技術趨勢和行業見解，以幫助決策者做出明智的戰略決策。它還分析了市場的成長促進因素、挑戰和競爭動態。

目錄

第1章 研究框架

第2章 執行摘要

第3章 全球醫學圖像分析軟體市場洞察

  • 行業價值鏈分析
  • DROC分析
    • 成長動力
      • 慢性病患病率增加
      • 將人工智慧融入醫學圖像分析軟體
      • 對效率和效益的需求不斷成長
    • 抑制因素
      • 預算限制
      • 人們對軟體合規性和安全性的擔憂日益增加
    • 機會
      • 技術進步
    • 任務
      • 缺乏熟練的專業人員
  • 技術進步/最新發展
  • 監管框架
  • 波特五力分析

第4章 全球醫學圖像分析軟體市場概述

  • 2019-2029年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 通過軟體
      • 整合軟體
      • 獨立軟體
    • 按方式
      • 斷層掃描
      • CT檢查
      • 磁共振成像
      • 正電子發射斷層掃描
      • 單光子發射斷層掃描
      • 超聲成像
      • 射線照相成像
      • 聯合模式
    • 通過成像
      • 二維成像
      • 3D成像
      • 4D成像
    • 按用途
      • 骨科
      • 牙科
      • 神經病學
      • 心臟病學
      • 腫瘤學
      • 婦產科
      • 乳房X光檢查
      • 泌尿外科和腎臟病學
    • 按最終用途
      • 醫院
      • 診斷中心
      • 日間手術中心 (ASC)
      • 其他（學術研究中心）
    • 按地區
      • 北美
      • 歐洲
      • 亞太地區 (APAC)
      • 拉丁美洲 (LATAM)
      • 中東和非洲 (MEA)

第5章 北美醫學圖像分析軟體市場

  • 2019-2029年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 通過軟體
    • 按方式
    • 通過成像
    • 按用途
    • 按最終用戶
    • 按國家/地區
      • 美國
      • 加拿大

第6章 歐洲醫學圖像分析軟體市場

  • 2019-2029年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 通過軟體
    • 按方式
    • 通過成像
    • 按用途
    • 按最終用戶
    • 按國家/地區
      • 德國
      • 英國
      • 義大利
      • 法國
      • 西班牙
      • 比利時
      • 俄羅斯
      • 荷蘭
      • 其他歐洲國家

第7章 亞太醫學圖像分析軟體市場

  • 2019-2029年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 通過軟體
    • 按方式
    • 通過成像
    • 按用途
    • 按最終用戶
    • 按國家/地區
      • 中國
      • 印度
      • 日本
      • 韓國
      • 澳大利亞和紐西蘭
      • 印度尼西亞
      • 馬來西亞
      • 新加坡
      • 越南
      • 亞太地區其他國家

第8章 拉丁美洲醫學圖像分析軟體市場

  • 2019-2029年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 通過軟體
    • 按方式
    • 通過成像
    • 按用途
    • 按最終用戶
    • 按國家/地區
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘魯
      • 拉丁美洲其他地區

第9章 中東和非洲醫學圖像分析軟體市場

  • 2019-2029年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 通過軟體
    • 按方式
    • 通過成像
    • 按用途
    • 按最終用戶
    • 按國家/地區
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 科威特
      • 南非
      • 奈及利亞
      • 阿爾及利亞
      • MEA 的其餘部分

第10章 競爭格局

  • 主要公司及其產品列表
  • 圖：2022年全球醫學圖像分析軟體企業市場佔有率分析
  • 通過管理參數進行競爭基準測試
  • 主要戰略發展（合併、收購、合作夥伴關係等）

第11章COVID-19 對全球醫學圖像分析軟體市場的影響

第12章公司簡介（公司簡介、財務矩陣、競爭格局、關鍵人才、主要競爭、聯繫地址、戰略展望、SWOT分析）

  • Toshiba Medical Systems Corp.
  • Bruker Corp.
  • Xinapse Systems Ltd.
  • Esaote, Inc.
  • ClaroNAv, Inc.
  • Merge Healthcare Inc.
  • Aquilab GmbH
  • Spacelabs Healthcare, Inc.
  • MIM Software Inc.
  • Carestream Health, Inc.
  • Agfa-Gevaert Corp.
  • Philips Healthcare
  • Siemens Healthineers
  • GE Healthcare
  • Other Prominent Players

第13章關鍵戰略建議

第14章調查方法

  • 定性研究
    • 初級和次級研究
  • 定量研究
  • 市場細分和數據三角測量
    • 二次調查
    • 初步調查
  • 主要調查受訪者的地區分佈
  • 假設和限制
簡介目錄
Product Code: BWC23522

Global Medical Image Analysis Software Market Size Set to Cross USD 5.62 Billion by 2029

Global medical image analysis software market is flourishing due to the increasing use of ultrasonic imaging equipment for faster diagnosis, particularly of persistent illnesses, and the growing adoption of technologically advanced medical image equipment, such as multimodality imaging platforms and 3D imaging.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the global medical image analysis software market size at USD 3.30 billion in 2022. During the forecast period between 2023 and 2029, BlueWeave expects the global medical image analysis software market size to grow at a CAGR of 7.80% reaching a value of USD 5.62 billion by 2029. The increasing use of ultrasonic imaging equipment for faster diagnosis, particularly of persistent illnesses, is likely to drive the demand for medical image analysis software. The increasing adoption of technologically advanced products, such as multimodality imaging platforms and 3D imaging, as well as the benefits of using these systems, such as high-resolution imaging, ease of use, and flexibility, is driving rising consumer demand. The growing elderly population has increased the number of chronic diseases. The rising prevalence of such disorders may increase the use of diagnostic imaging technologies, enhancing the market for medical imaging analysis software.

Opportunity: Introduction of CT-guided diagnosis

Radiation exposure for patients and medical staff has gradually increased with the advent of CT-guided diagnosis and intervention, including nuclear medicine-based scans and angiography. As a result, statutory organizations have made it essential for patients' radiation exposure to be monitored and reported in their medical records. It is also crucial to monitor how much radiation doctors are exposed to while performing their duties. For instance, DoseWatch is a program offered by GE to keep track of the radiation doses supplied to patients at a certain facility. Data can be categorized according to devices, protocols, or operators to make it easier to find dose outliers. Sectra provides web-based dose tracking. Sectra is attributed by the American College of Radiology and may transmit dosage data directly from a hospital to its Dose Index Registry. Therefore, the increasing number of the introduction of CT-guided diagnosis is expected to create lucrative opportunities for the growth of the global medical image analysis software market in the coming years.

Restraint: Budgetary constraints

The global medical image analysis software market is projected to encounter budgetary constraints, due to a variety of factors, including limited funding for healthcare R&D, the high cost of developing and maintaining these software solutions, and by healthcare providers and organizations. The high cost of developing and sustaining these solutions is one of the major constraints for medical image analysis software suppliers. The development of these software solutions requires significant R&D investment, including the expense of employing trained individuals, developing and testing algorithms, and gathering high-quality imaging data. The ongoing maintenance and support of these software solutions can be expensive. These factors may hamper market growth in the coming years.

Impact of COVID-19 on Global Medical Image Analysis Software Market

The global medical image analysis software market was significantly impacted by the COVID-19 pandemic. Considering the importance of medical imaging in diagnosing and treating severe COVID-19 infections, the medical imaging sector witnessed considerable growth during the COVID-19 pandemic. Medical imaging software methods are also used in the care of COVID-19 patients. Chest X-rays, CT scans, and ultrasonography were commonly used to identify the extent of COVID-19 infections and the disease's progress in the lungs. All of these factors led to a rise in global market demand. Thus, the COVID-19 pandemic positively impacted the global medical image analysis software market growth.

Global Medical Image Analysis Software Market - By Application:

Based on application, the global medical image analysis software market is divided into orthopedic, dental, neurology, cardiology, oncology, obstetrics & gynecology, mammography, and urology & nephrology segments. Neurology is expected to be the fastest-growing application segment during the forecast period, due to a rising incidence of brain cancer, tumors, and other brain-related ailments, which is expected to drive the market growth for medical image analysis software over the forecast period. The increased emphasis on the most recent technological advances in the medical industry has a significant impact on the market expansion.

Global Medical Image Analysis Software Market - By End User:

Based on end user, the global medical image analysis software market is segmented into hospitals, diagnostic centers, ambulatory surgical centers (ASCS), and others (academic & research centers). The hospitals segment dominated the market and accounted for a significant market share. Supportive infrastructure, which is essential in performing surgical interventions using medical imaging software, is one of the important reasons for supporting the segment's expansion. Hospitals have a larger installed base of diagnostic imaging systems and solutions than research and diagnostic centers. Patient inflow is significantly higher. It keeps the end-use portion in the first place.

Global Medical Image Analysis Software Market - By Region:

Asia Pacific is expected to grow significantly in the global medical image analysis software market during the period in analysis. Rising investments in healthcare, improved healthcare infrastructure, and increasing adoption of medical imaging devices, AI, and telehealth services are expected to drive the growth of this regional market. Economic development in APAC has greatly boosted access to healthcare and improved healthcare infrastructure. The region's healthcare sector is expected to undergo significant change over the next five years.

Competitive Landscape:

The global medical image analysis software market is highly competitive, with all the players continually competing to gain a larger market share. Key players in the market include Toshiba Medical Systems Corp., Bruker Corp., Xinapse Systems Ltd., Esaote, Inc., ClaroNAv, Inc., Merge Healthcare Inc., Aquilab GmbH, Spacelabs Healthcare, Inc., MIM Software Inc., Carestream Health, Inc., Agfa-Gevaert Corp., Philips Healthcare, Siemens Healthineers, and GE Healthcare.

The report's in-depth analysis provides information about growth potential, upcoming trends, and the Global Medical Image Analysis Software Market statistics. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the global Global Medical image analysis software Market along with industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyses the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Medical Image Analysis Software Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Increasing Prevalence of Chronic Diseases
      • 3.2.1.2. Incorporation of AI in Medical Image Analysis Software
      • 3.2.1.3. Rising Need for Efficiency and Effectiveness
    • 3.2.2. Restraints
      • 3.2.2.1. Budgetary Constraints
      • 3.2.2.2. Increasing Concern Regarding the Compliance and Security of Software
    • 3.2.3. Opportunities
      • 3.2.3.1. Advancement in technology
    • 3.2.4. Challenges
      • 3.2.4.1. Lack of Skilled Professionals
  • 3.3. Technology Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Medical Image Analysis Software Market Overview

  • 4.1. Market Size & Forecast, 2019-2029
    • 4.1.1. By Value (USD Million)
  • 4.2. Market Share & Forecast
    • 4.2.1. By Software
      • 4.2.1.1. Integrated Software
      • 4.2.1.2. Stand-alone Software
    • 4.2.2. By Modality
      • 4.2.2.1. Tomography
      • 4.2.2.1.1. Computed Tomography
      • 4.2.2.1.2. Magnetic Resonance Imaging
      • 4.2.2.1.3. Positron Emission Tomography
      • 4.2.2.1.4. Single-Photon Emission Tomography
      • 4.2.2.2. Ultrasound Imaging
      • 4.2.2.3. Radiographic Imaging
      • 4.2.2.4. Combined Modalities
    • 4.2.3. By Imaging
      • 4.2.3.1. 2D Imaging
      • 4.2.3.2. 3D Imaging
      • 4.2.3.3. 4D Imaging
    • 4.2.4. By Application
      • 4.2.4.1. Orthopedic
      • 4.2.4.2. Dental
      • 4.2.4.3. Neurology
      • 4.2.4.4. Cardiology
      • 4.2.4.5. Oncology
      • 4.2.4.6. Obstetrics & Gynecology
      • 4.2.4.7. Mammography
      • 4.2.4.8. Urology & Nephrology
    • 4.2.5. By End Use
      • 4.2.5.1. Hospitals
      • 4.2.5.2. Diagnostic Centers
      • 4.2.5.3. Ambulatory Surgical Centers (ASCs)
      • 4.2.5.4. Others (Academic & Research Centers)
    • 4.2.6. By Region
      • 4.2.6.1. North America
      • 4.2.6.2. Europe
      • 4.2.6.3. Asia Pacific (APAC)
      • 4.2.6.4. Latin America (LATAM)
      • 4.2.6.5. Middle East and Africa (MEA)

5. North America Medical Image Analysis Software Market

  • 5.1. Market Size & Forecast, 2019-2029
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Software
    • 5.2.2. By Modality
    • 5.2.3. By Imaging
    • 5.2.4. By Application
    • 5.2.5. By End User
    • 5.2.6. By Country
      • 5.2.6.1. United States
      • 5.2.6.1.1. By Software
      • 5.2.6.1.2. By Modality
      • 5.2.6.1.3. By Imaging
      • 5.2.6.1.4. By Application
      • 5.2.6.1.5. By End User
      • 5.2.6.2. Canada
      • 5.2.6.2.1. By Software
      • 5.2.6.2.2. By Modality
      • 5.2.6.2.3. By Imaging
      • 5.2.6.2.4. By Application
      • 5.2.6.2.5. By End User

6. Europe Medical Image Analysis Software Market

  • 6.1. Market Size & Forecast, 2019-2029
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Software
    • 6.2.2. By Modality
    • 6.2.3. By Imaging
    • 6.2.4. By Application
    • 6.2.5. By End User
    • 6.2.6. By Country
      • 6.2.6.1. Germany
      • 6.2.6.1.1. By Software
      • 6.2.6.1.2. By Modality
      • 6.2.6.1.3. By Imaging
      • 6.2.6.1.4. By Application
      • 6.2.6.1.5. By End User
      • 6.2.6.2. United Kingdom
      • 6.2.6.2.1. By Software
      • 6.2.6.2.2. By Modality
      • 6.2.6.2.3. By Imaging
      • 6.2.6.2.4. By Application
      • 6.2.6.2.5. By End User
      • 6.2.6.3. Italy
      • 6.2.6.3.1. By Software
      • 6.2.6.3.2. By Modality
      • 6.2.6.3.3. By Imaging
      • 6.2.6.3.4. By Application
      • 6.2.6.3.5. By End User
      • 6.2.6.4. France
      • 6.2.6.4.1. By Software
      • 6.2.6.4.2. By Modality
      • 6.2.6.4.3. By Imaging
      • 6.2.6.4.4. By Application
      • 6.2.6.4.5. By End User
      • 6.2.6.5. Spain
      • 6.2.6.5.1. By Software
      • 6.2.6.5.2. By Modality
      • 6.2.6.5.3. By Imaging
      • 6.2.6.5.4. By Application
      • 6.2.6.5.5. By End User
      • 6.2.6.6. Belgium
      • 6.2.6.6.1. By Software
      • 6.2.6.6.2. By Modality
      • 6.2.6.6.3. By Imaging
      • 6.2.6.6.4. By Application
      • 6.2.6.6.5. By End User
      • 6.2.6.7. Russia
      • 6.2.6.7.1. By Software
      • 6.2.6.7.2. By Modality
      • 6.2.6.7.3. By Imaging
      • 6.2.6.7.4. By Application
      • 6.2.6.7.5. By End User
      • 6.2.6.8. The Netherlands
      • 6.2.6.8.1. By Software
      • 6.2.6.8.2. By Modality
      • 6.2.6.8.3. By Imaging
      • 6.2.6.8.4. By Application
      • 6.2.6.8.5. By End User
      • 6.2.6.9. Rest of Europe
      • 6.2.6.9.1. By Software
      • 6.2.6.9.2. By Modality
      • 6.2.6.9.3. By Imaging
      • 6.2.6.9.4. By Application
      • 6.2.6.9.5. By End User

7. Asia-Pacific Medical Image Analysis Software Market

  • 7.1. Market Size & Forecast, 2019-2029
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Software
    • 7.2.2. By Modality
    • 7.2.3. By Imaging
    • 7.2.4. By Application
    • 7.2.5. By End User
    • 7.2.6. By Country
      • 7.2.6.1. China
      • 7.2.6.1.1. By Software
      • 7.2.6.1.2. By Modality
      • 7.2.6.1.3. By Imaging
      • 7.2.6.1.4. By Application
      • 7.2.6.1.5. By End User
      • 7.2.6.2. India
      • 7.2.6.2.1. By Software
      • 7.2.6.2.2. By Modality
      • 7.2.6.2.3. By Imaging
      • 7.2.6.2.4. By Application
      • 7.2.6.2.5. By End User
      • 7.2.6.3. Japan
      • 7.2.6.3.1. By Software
      • 7.2.6.3.2. By Modality
      • 7.2.6.3.3. By Imaging
      • 7.2.6.3.4. By Application
      • 7.2.6.3.5. By End User
      • 7.2.6.4. South Korea
      • 7.2.6.4.1. By Software
      • 7.2.6.4.2. By Modality
      • 7.2.6.4.3. By Imaging
      • 7.2.6.4.4. By Application
      • 7.2.6.4.5. By End User
      • 7.2.6.5. Australia & New Zealand
      • 7.2.6.5.1. By Software
      • 7.2.6.5.2. By Modality
      • 7.2.6.5.3. By Imaging
      • 7.2.6.5.4. By Application
      • 7.2.6.5.5. By End User
      • 7.2.6.6. Indonesia
      • 7.2.6.6.1. By Software
      • 7.2.6.6.2. By Modality
      • 7.2.6.6.3. By Imaging
      • 7.2.6.6.4. By Application
      • 7.2.6.6.5. By End User
      • 7.2.6.7. Malaysia
      • 7.2.6.7.1. By Software
      • 7.2.6.7.2. By Modality
      • 7.2.6.7.3. By Imaging
      • 7.2.6.7.4. By Application
      • 7.2.6.7.5. By End User
      • 7.2.6.8. Singapore
      • 7.2.6.8.1. By Software
      • 7.2.6.8.2. By Modality
      • 7.2.6.8.3. By Imaging
      • 7.2.6.8.4. By Application
      • 7.2.6.8.5. By End User
      • 7.2.6.9. Vietnam
      • 7.2.6.9.1. By Software
      • 7.2.6.9.2. By Modality
      • 7.2.6.9.3. By Imaging
      • 7.2.6.9.4. By Application
      • 7.2.6.9.5. By End User
      • 7.2.6.10. Rest of APAC
      • 7.2.6.10.1. By Software
      • 7.2.6.10.2. By Modality
      • 7.2.6.10.3. By Imaging
      • 7.2.6.10.4. By Application
      • 7.2.6.10.5. By End User

8. Latin America Medical Image Analysis Software Market

  • 8.1. Market Size & Forecast, 2019-2029
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Software
    • 8.2.2. By Modality
    • 8.2.3. By Imaging
    • 8.2.4. By Application
    • 8.2.5. By End User
    • 8.2.6. By Country
      • 8.2.6.1. Brazil
      • 8.2.6.1.1. By Software
      • 8.2.6.1.2. By Modality
      • 8.2.6.1.3. By Imaging
      • 8.2.6.1.4. By Application
      • 8.2.6.1.5. By End User
      • 8.2.6.2. Mexico
      • 8.2.6.2.1. By Software
      • 8.2.6.2.2. By Modality
      • 8.2.6.2.3. By Imaging
      • 8.2.6.2.4. By Application
      • 8.2.6.2.5. By End User
      • 8.2.6.3. Argentina
      • 8.2.6.3.1. By Software
      • 8.2.6.3.2. By Modality
      • 8.2.6.3.3. By Imaging
      • 8.2.6.3.4. By Application
      • 8.2.6.3.5. By End User
      • 8.2.6.4. Peru
      • 8.2.6.4.1. By Software
      • 8.2.6.4.2. By Modality
      • 8.2.6.4.3. By Imaging
      • 8.2.6.4.4. By Application
      • 8.2.6.4.5. By End User
      • 8.2.6.5. Rest of LATAM
      • 8.2.6.5.1. By Software
      • 8.2.6.5.2. By Modality
      • 8.2.6.5.3. By Imaging
      • 8.2.6.5.4. By Application
      • 8.2.6.5.5. By End User

9. Middle East & Africa Medical Image Analysis Software Market

  • 9.1. Market Size & Forecast, 2019-2029
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Software
    • 9.2.2. By Modality
    • 9.2.3. By Imaging
    • 9.2.4. By Application
    • 9.2.5. By End User
    • 9.2.6. By Country
      • 9.2.6.1. Saudi Arabia
      • 9.2.6.1.1. By Software
      • 9.2.6.1.2. By Modality
      • 9.2.6.1.3. By Imaging
      • 9.2.6.1.4. By Application
      • 9.2.6.1.5. By End User
      • 9.2.6.2. UAE
      • 9.2.6.2.1. By Software
      • 9.2.6.2.2. By Modality
      • 9.2.6.2.3. By Imaging
      • 9.2.6.2.4. By Application
      • 9.2.6.2.5. By End User
      • 9.2.6.3. Qatar
      • 9.2.6.3.1. By Software
      • 9.2.6.3.2. By Modality
      • 9.2.6.3.3. By Imaging
      • 9.2.6.3.4. By Application
      • 9.2.6.3.5. By End User
      • 9.2.6.4. Kuwait
      • 9.2.6.4.1. By Software
      • 9.2.6.4.2. By Modality
      • 9.2.6.4.3. By Imaging
      • 9.2.6.4.4. By Application
      • 9.2.6.4.5. By End User
      • 9.2.6.5. South Africa
      • 9.2.6.5.1. By Software
      • 9.2.6.5.2. By Modality
      • 9.2.6.5.3. By Imaging
      • 9.2.6.5.4. By Application
      • 9.2.6.5.5. By End User
      • 9.2.6.6. Nigeria
      • 9.2.6.6.1. By Software
      • 9.2.6.6.2. By Modality
      • 9.2.6.6.3. By Imaging
      • 9.2.6.6.4. By Application
      • 9.2.6.6.5. By End User
      • 9.2.6.7. Algeria
      • 9.2.6.7.1. By Software
      • 9.2.6.7.2. By Modality
      • 9.2.6.7.3. By Imaging
      • 9.2.6.7.4. By Application
      • 9.2.6.7.5. By End User
      • 9.2.6.8. Rest of MEA
      • 9.2.6.8.1. By Software
      • 9.2.6.8.2. By Modality
      • 9.2.6.8.3. By Imaging
      • 9.2.6.8.4. By Application
      • 9.2.6.8.5. By End User

10. Competitive Landscape

  • 10.1. List of Key Players and Their Offerings
  • 10.2. Global Medical Image Analysis Software Company Market Share Analysis, 2022
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Medical Image Analysis Software Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

  • 12.1. Toshiba Medical Systems Corp.
  • 12.2. Bruker Corp.
  • 12.3. Xinapse Systems Ltd.
  • 12.4. Esaote, Inc.
  • 12.5. ClaroNAv, Inc.
  • 12.6. Merge Healthcare Inc.
  • 12.7. Aquilab GmbH
  • 12.8. Spacelabs Healthcare, Inc.
  • 12.9. MIM Software Inc.
  • 12.10. Carestream Health, Inc.
  • 12.11. Agfa-Gevaert Corp.
  • 12.12. Philips Healthcare
  • 12.13. Siemens Healthineers
  • 12.14. GE Healthcare
  • 12.15. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations